Cooperative Agreement 15PBJA22GK03114PDMP

Award Date 10/1/22
Completion Date 9/30/26
Dollars Obligated $1.4M
Federal Grant Program
16.754
Assistance Type
Cooperative Agreement
Place of Performance
Denver, CO 80202, USA
Similar Awards
The Department of Health and Human Services Agency for Healthcare Research and Quality awarded Oregon State University a $740,620 Project Grant under the Research on Healthcare Costs, Quality and Outcomes program (CFDA 93.226) to evaluate the integration of state prescription drug monitoring programs into electronic health records. Oregon Health & Science University and Comagine Health were named as sub-awardees to provide integration services for OHSU's Epic EHR system and support...
The Massachusetts Department of Public Health (MDPH) received a $1,993,123 federal Project Grant award from the U.S. Department of Justice, Bureau of Justice Assistance under the Harold Rogers Prescription Drug Monitoring Program (CFDA 16.754). The grant funding will support two principal enhancement objectives: Development of a "buprenorphine prompt" functionality within the Massachusetts Prescription Monitoring Program (MA PMP) to alert prescribers of gaps in buprenorphine...
The University of California, Davis (UC Davis) received a $1,000,000 Cooperative Agreement award from the Bureau of Justice Assistance's Harold Rogers Prescription Drug Monitoring Program (CFDA 16.754) to strengthen the capacity of the California Prescription Drug Monitoring Program (PDMP) to generate and implement updated, evidence-based patient safety alerts. The project objectives are to: 1) analyze linked PDMP and mortality data to identify prescribing patterns associated with overdose risk,...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a 5-year, $2,726,432 research study on co-use of cannabis and prescription opioids among emerging adults in medical settings. The study will enroll emerging adults aged 18-25 who either have no history of cannabis use or have used cannabis in the past month and are prescribed an opioid for acute pain management. Participants will be followed...
This $385,000 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to advance integrated treatment for co-occurring opioid use disorder (OUD) and alcohol use disorder (AUD) in real-world settings. The key objectives are to: Assess the effectiveness of integrated treatment approaches, including first-line medications and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), for patients with co-occurring OUD...
This $1,000,000 Project Grant award from the U.S. Department of Justice's Bureau of Justice Assistance under the Harold Rogers Prescription Drug Monitoring Program (CFDA 16.754) aims to enhance the capacity of Puerto Rico's Mental Health and Anti-Addiction Services Administration (ASSMCA) to prevent prescription drug misuse and opioid-related harm across the territory. The key products and services to be delivered include: 1) Achieving a 20% reduction in alerts among flagged adults at risk of...
The State of Alaska Department of Health received a $1,266,452 Project Grant from the U.S. Department of Justice, Bureau of Justice Assistance, under the Harold Rogers Prescription Drug Monitoring Program (CFDA 16.754). This funding will allow Alaska to advance existing and implement new strategies to monitor controlled substance prescriptions through the state's Prescription Drug Monitoring Program (PDMP). Key objectives include: providing resources to assist with PDMP compliance monitoring and...
The Utah Department of Health and Human Services (UDHHS) was awarded a $2,000,000 Project Grant from the U.S. Department of Justice Bureau of Justice Assistance under the Harold Rogers Prescription Drug Monitoring Program (CFDA 16.754). The grant will fund enhancements to Utah's Controlled Substance Database (CSD), the state's prescription drug monitoring program, over a two-year period from October 1, 2023 to September 30, 2025. Specifically, the grant will support the development of tools to...
The U.S. Department of Justice's Bureau of Justice Assistance awarded a $405,286 Project Grant under the Harold Rogers Prescription Drug Monitoring Program (CFDA 16.754) to the Connecticut Department of Consumer Protection, Drug Control Division. The grant aims to support the state's Prescription Monitoring Program (PMP) in detecting and preventing the diversion and misuse of controlled substances, ultimately reducing accidental overdose deaths and promoting responsible prescribing practices....
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $823,809 to the University of Pittsburgh to develop and validate a suite of multidimensional measures of access to Medications for Opioid Use Disorder (MOUD) across U.S. states and the District of Columbia. The primary objectives are to: Create a Small Area Multidimensional MOUD Access (SAMMA) measure suite using public data sources. Validate and...

IMPROVING PRESCRIPTION DRUG MONITORING (PDMP) USE AND THE SAFETY OF CONTROLLED MEDICATION PRESCRIBING IS A PILLAR OF THE NATIONAL RESPONSE TO THE WORSENING OPIOID CRISIS. A STATED PURPOSE OF THE FUNDING IS TO ENHANCE THE CAPACITY OF PUBLIC HEALTH OFFICIALS TO COLLECT AND ANALYZE CONTROLLED SUBSTANCE PRESCRIPTION DATA, STRENGTHENING STATES' ABILITY TO ENHANCE PDMPS BY ACCOMMODATING LOCAL DECISION-MAKING AND ENCOURAGING PROMISING PRACTICES. THE EVIDENCE BASE FOR PDMPS WOULD BENEFIT GREATLY FROM RESEARCH PRODUCING HIGH QUALITY, ACTIONABLE DATA LINKING AND MEASURING PDMP USE AND IMPORTANT PATIENT OUTCOMES. DATA SILOS COMMONLY LIMIT THE MEASUREMENT OF PDMP UTILIZATION AND THE LINKAGE OF PDMP USE TO PROVIDER PRESCRIBING ACTIONS. BEST PRACTICE DATA LINKAGE STRATEGIES CAN FACILITATE A ROBUST EVALUATION OF PDMP EFFECTIVENESS AND, SPECIFICALLY, THE IMPACT OF COLORADO'S NEW PDMP REGULATIONS WHICH MANDATE PDMP CHECKS PRIOR TO OPIOID AND BENZODIAZEPINE PRESCRIPTIONS WITH CERTAIN EXCEPTIONS. THE OBJECTIVE OF THIS PROJECT IS TO IMPROVE DATA ARCHITECTURE ACROSS COLORADO'S LARGEST HOSPITAL SYSTEM TO EFFECTIVELY MEASURE CLINICIAN PDMP USE TO ADDRESS GAPS DATA, COMPLIANCE WITH STATUTES, AND IMPORTANT OUTCOMES ASSOCIATED WITH NEW PDMP REGULATIONS. BY FACILITATING ROBUST EVALUATIONS OF PROCESS (E.G., PDMP USE, OPIOID PRESCRIBING) AND PATIENT OUTCOMES (E.G., FUTURE OPIOID USE, CO-PRESCRIBING, DEATH), THIS DATA SYSTEM WILL EXPEDITE THE MEASUREMENT OF PDMP EFFECTIVENESS ON CHANGING OPIOID PRESCRIBING. FURTHER, EVALUATION OF CLINICAL DECISION SUPPORT (CDS) TO PROMOTE COMPLIANCE WITH REGULATION CAN DETERMINE IF MANDATES RESULT IN INCREASED PDMP USE, DECREASED OPIOID EXPOSURES, HIGH-RISK PRESCRIPTIONS, MORBIDITY, AND MORTALITY. THIS PROJECT WILL ENHANCE THE PDMP IN THREE KEY WAYS: ADDRESS INEFFICIENCIES OF COLLECTING PDMP USE DATA. IMPROVED COLLECTION OF PDMP DATA AT THE PATIENT VISIT LEVEL WILL ALLOW FOR RAPID ANALYSIS OF PDMP USE AND INTERVENTIONS. IMPLEMENT EFFECTIVE PDMP INTERVENTIONS. PDMP CDS TOOLS CAN ACCELERATE THE UPTAKE OF MANDATED PDMP ACTIONS WHILE ROUTINE DATA COLLECTION CAN BE USED TO ASSESS OUTCOMES. ADDRESS SUSTAINABILITY. HEALTH SYSTEM WIDE IMPLEMENTATION WILL STRENGTHEN CAPACITY TO RAPIDLY EVALUATE THE EFFECTIVENESS OF MULTIPLE NEW PDMP POLICY INTERVENTIONS. THE PROPOSED PROJECT WILL ACHIEVE THIS USING A SINGLE SYSTEM, PRAGMATIC, CLUSTER RANDOMIZED TRIAL OF CDS TO DELIVER NEW STATE MANDATED PDMP REGULATIONS COMPARED TO USUAL CARE TO EVALUATE: PDMP USE, REGULATORY COMPLIANCE, AND ASSOCIATED PATIENT OUTCOMES. THIS WILL BE PERFORMED ACROSS THE UCHEALTH SYSTEM IN COLLABORATION WITH COLORADO DEPARTMENT OF REGULATORY AGENCIES (DORA) TO MAXIMIZE THE QUALITY AND IMPACT OF THE WORK AND GENERATE NOVEL, GENERALIZABLE KNOWLEDGE TO SUPPORT THE PROGRESS OF PDMPS.

Posted 9/27/22